Showing results (11-20 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Allergy and Clinical Immunology|September 10, 2004
Primary immunodeficiency diseases: an updateLuigi Notarangelo, Jean-Laurent Casanova, Alain Fischer, et al.Transplantation|June 9, 2005
Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patientsTayfun Güngör, Jörg Halter, Anne Klink, et al.The Journal of Allergy and Clinical Immunology|May 10, 2006
Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005Luigi Notarangelo, Jean-Laurent Casanova, Mary Ellen Conley, et al.Matters|April 23, 2019
Lentiviral gene therapy vector with UCOE stably restores function in iPSC-derived neutrophils of a CDG patientWalther Haenseler, Elena Kuzmenko, Adjoa Smalls-Mantey, et al.Blood|April 14, 2005
Siglec-9 transduces apoptotic and nonapoptotic death signals into neutrophils depending on the proinflammatory cytokine environmentStephan von Gunten, Shida Yousefi, Michael Seitz, et al.Plos One|January 26, 2010
MHC class II molecules enhance Toll-like receptor mediated innate immune responsesRemo Frei, Johanna Steinle, Thomas Birchler, et al.Journal of Hematotherapy & Stem Cell Research|August 31, 2002
Mobilization and transduction of CD34(+) peripheral blood stem cells in patients with X-linked chronic granulomatous diseaseMarion-Gabriele Ott, Heike Merget-Millitzer, Oliver Gerhard Ottmann, et al.Swiss Medical Weekly|March 30, 2010
Hematopoietic stem cell transplantation in Switzerland: a comprehensive quality control report on centre effectJakob Passweg, Helen Baldomero, Martin Stern, et al.European Journal of Immunology|October 16, 2007
Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic childrenSonja Junge, Barbara Kloeckener-Gruissem, Romain Zufferey, et al.Human Gene Therapy Methods|March 16, 2013
Human miR223 promoter as a novel myelo-specific promoter for chronic granulomatous disease gene therapyChristian Brendel, Walther Hänseler, Vital Wohlgensinger, et al.Pageof 4